Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Referral and approach to care. o Heart failure multidisciplinary team. o Transfer of care between secondary and primary care services. Information and support. o Information and support on diagnosis and prognosis for people with chronic heart failure, their families and carers. Supportive and palliative care. o Domiciliary oxygen therapy. o Parenteral and intravenous diuretics. o Criteria for withdrawing treatment and device inactivation. Areas not in the published guideline that will be included in the update How to manage chronic heart failure in different subgroups: o People with iron deficiency. o People with chronic kidney disease (estimated glomerular filtration rate [eGFR] less than with or without markers of kidney damage). o People with chronic heart failure and secondary atrial fibrillation. o People aged over 75. Pharmacological therapies. o Beta-blockers in people with chronic heart failure and secondary atrial fibrillation. Palliative care. o Referral to palliative care. o Delivery of diuretics Monitoring heart failure. o Role of cardiac MRI. For further details please refer to the scope in appendix L and the review questions in section 4.1. 3.3.2 What this guideline does not cover Areas from the published guideline that will not be updated Symptoms and signs in diagnosing heart failure. Clinical review and monitoring of serum digoxin. Lifestyle. o Sexual activity, vaccination and air travel. Areas from the published guideline that will be removed General. o Age. o Gender. Pharmacological agents. o Aspirin. Chronic Heart Failure Development of the guideline NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 o Statins. Heart failure caused by valve disease. Management of depression and anxiety. Benefit of other therapies such as homeopathy, reflexology, hydrotherapy, crystal therapy and acupuncture. Referral for invasive procedures. o Implantable cardiac defibrillators. Valve surgery. Non-NHS agencies. Lifestyle. 